Sensitivity analysis
Several sensitivity analyses were performed to evaluate the robustness and stability of our results, especially the universal testing policy. The probability of gBRCA mutation, probability of gBRCA mutation in patients without a family history, probability of family history and cost of olaparib contributed significantly to the variation in the results (Figs. 